We herein report the anti-diabetic effect of the natural friedelan tritepenoid, 4-oxa-3, 4-secofriedelan (cerin), isolated from cork tissue of Quercus suber L. and its oxygenated derivative, 4-oxa-3, 4-secofriedelan-3-oic acid (cerin ox ) in streptozotocin (STZ)-induced diabetic rat. Male Sprague Dawley rats were randomized into four groups: non-diabetic control (Group I), STZ-induced diabetic rats (Group II), STZ-induced diabetic rats treated with cerin (Group III), and STZ-induced diabetic rats treated with cerin ox (Group IV). Administration of cerin (3mg/kg) and cerin ox (3mg/kg) orally to STZ-diabetic rats for three weeks improved the body weight, reduced serum glucose level and activities of alkaline phosphatase, acid phosphatase, glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase, and restored liver antioxidant status.
Diabetes mellitus (DM) is a foremost health problem worldwide. It is an endocrine disorder characterized by hyperglycemia. In the majority of patients, diabetes is brought about either by the autoimmune destruction of insulin producing pancreatic β cells (Type-1 Diabetes) or by a combination of genetic and environmental factors that affect the organism's ability to respond to insulin (Type-II Diabetes). DM is threatening because of the development of many secondary complications, including atherosclerosis, microangiopathy, renal dysfunction and failure, cardiac abnormalities, diabetic retinopathy and ocular disease [1, 2] . The disease has become widespread and according to the report of the World Health Organization (WHO), the number of patients with diabetes worldwide will double by the year 2025, from the current number of approximately 150 million to 300 million [3] .
All current therapies target only the consequences of diabetes.The two most popular therapeutic agents now in use are the thiazolidinediones (TZDs) and the biguanides. TZDs are widely used but can have undesirable side effects, like weight gain, fluid retention, and heart failure [4, 5] . Biguanides are known to reduce hepatic glucose production, enhance peripheral glucose utilization and reduce intestinal glucose absorption. The biguanide, metformin mainly acts in liver rather than muscle and thus on its own is not a complete therapy. Therefore, there is a worldwide search for better agents [4, 6] .
Traditional medicines (TM) or complementary medicines are valuable source of future drugs to counteract DM. TMs have been used to treat diseases for several years and there is considerable information available regarding their efficacy and safety, the two confounding problems associated with new drug entries. Synthetic transformation of natural compounds to more efficient biologically active agents has become an actively advancing scientific direction for drug development. Hence, it is essential to identify the natural active ingredients and to investigate the specific effects of natural products and their structural derivatives in well-defined biological systems and animal models relevant to humans [7] .
Naturally occurring triterpenoids are a large, ubiquitous and structurally diverse group of molecules. Several studies have revealed triterpenoids and their derivatives as potent cellular differentiating, antiproliferative, proapoptotic, anti-inflammatory and anticarcinogenic agents [8, 9] . Some triterpenoids, like 2cyano-3, 12-dioxooleana-1, 9-dien-28-oic-acid (CDDO), and its methyl ester, CDDO-Me, are undergoing clinical trials in cancer. CDDO-Me has also shown anti-diabetic activity [10] .
The cork tissue of Quercus suber L. is rich in phenolic compounds like phenol acids, phenol aldehydes, coumarins, tannins and triterpenoids. In our previous communication we reported the isolation of friedelan triterpenoids from cork tissue of Q. suber and chemical synthesis of their derivatives highly oxygenated in ring A and their structural characterization by IR, 1D-NMR, 2D-NMR spectroscopy and mass spectrometry [11] . We herein report the antidiabetic effect of the natural friedelan triterpenoid, cerin and one of its oxygenated derivatives, cerin ox , in STZ-induced diabetic rat. The antioxidant effect of the compounds was also evaluated by monitoring superoxide dismutase (SOD) and catalase (CAT) activitiesand reduced glutathione (GSH) level in hepatocytes.
Synthesis of oxygenated friedelan compounds:
The friedelan triterpenoid, cerin was isolated from bark of Q. suber (cork). The oxygenated hemi-syntheticfriedelan compound, 4-oxa-3, 4secofriedelan-3-oic acid (cerin ox ) was synthesized by oxidative cleavage of ring A of cerin ( Figure 1 ).
Anti-hyperglycemic effect of cerin and cerin ox in STZ-induced diabetic rats:
Sprague Dawley male rats were randomized into four groups: non-diabetic control (Group I), STZ-induced diabetic rats (Group II), STZ-induced diabetic rats treated with cerin (Group III), and STZ-induced diabetic rats treated with cerin ox (Group IV). STZ treatment of rats resulted in hyperglycemia (blood glucose level >250 mg/dL) within 48h. In Group II rats, the hyperglycemic condition prevailed throughout, with plasma glucose level raised to 450 mg/dL at three weeks of STZ treatment. Oral administration of cerin and cerin ox to diabetic rats reduced plasma glucose level. At three weeks of treatment, the average glucose levels were 180 and 164 mg/dL in rats of Groups III and IV, respectively. STZ treated rats of Group II exhibited a significant decline in body weight in comparison with that of the non-diabetic control (Group I). Oral administration of cerin and cerin ox markedly improved the body weight with greater increase in rats treated with cerin ( Figure 2 ). 
Effect of cerin and cerin ox in histology of liver and pancreas:
The histological section of pancreas of STZ-induced diabetic rats of Group II showed reduction in size and number of islets of langerhans. Some fields showed total absence of islets with formation of clear zones (Figure 3b ). The pancreatic islet cells of Group III rats treated with cerin maintained almost normal architecture. They had greater size with prominent darkly stained nucleus ( Figure 3c ). Although, cerin ox treatment also improved the histology of the pancreas of Group IV rats, it was less effective than cerin ( Figure 3d ).
The histological sections of liver of STZ-induced diabetic rats (Group II) showed hypertrophy of hepatocytes. The presence of clear patches indicated complete destruction of hepatocytes. The cell number was reduced and there were signs of tissue hemorrhage. Sinusoids were disrupted leading to great loss of histological structure (Figure 3f ). Treatment with cerin (Group III) greatly revived the histological structure with increased number of hepatocytes containing darkly stained nucleus. Interestingly, the shape of hepatocytes altered from elongated to oval (Figure 3g ). Previous studies have shown the ability of hepatic oval cells to trans-differentiate into insulin-producing cells, when cultured with high glucose concentration [12] . Treatment with cerin ox also improved the histology of liver; however, it was less effective than cerin (Figure 3h ).
Effect of cerin and cerin ox inglutamateoxaloacetate transaminase (SGOT), glutamate-pyruvate transaminase (SGPT), alkaline phosphatase (ALP) and acid phosphatase (ACP) activities and antioxidants:
To evaluate the effect of cerin and cerin ox in overall body functions, activities SGOT, SGPT, ALP and ACP were determined in blood plasma samples of various treatment groups. The histological alterations observed in liver of STZ-induced diabetic rats (Group II) were correlated with the increased activities of plasma SGOT and SGPT. In these rats, plasma SGOT and SGPT activities were raised to 92 U/mL and 80 U/mL, respectively, at three weeks of STZ-treatment ( Figure 4a ). Administration of cerin (Group III) and cerin ox (Group IV) to STZ-rats lowered the activities of SGPT to 10 and 16 U/mL and of SGOT to 21 and 23 U/mL, respectively. Increased levels of ALP and ACP enzymes are particularly associated with hepatopathy. The non-diabetic control rats (Group-I) had ALP and ACP activities of 19 and 8 KA/mL, respectively. These activities increased by more than two folds in the diabetic control (Group II) and reversed on treatment with cerin and cerin ox in Groups III and IV, respectively (Figure 4b ). Reactive oxygen species (ROS) are known to damage the cell membrane and other biological structures. Hyperglycemia increases production of ROS by affecting antioxidant reactions catalyzed by ROS scavenging enzymes [13] . The generation of ROS involves several mechanisms including, glucose and protein autoxidation. Several proteins like albumin, collagen, and low density lipoproteins (LDL) undergo glycation under diabetic conditions, which induce the formation of oxygen derived free radicals [14, 15] . The effect of cerin and cerin ox in oxidative stress was evaluated by measuring GSH level and catalytic activities of SOD and CAT in liver and the results are shown in Figure 5 . GSH content in Group I rats was about 22.3 μmol/mg protein, which was reduced to 13.5 μmol/mg in STZ-treated Group II rats. Treatment with cerin and cerin ox for three weeks increased the quantity of GSH to 19.7 and 16.8 μmol/mg in Group III and Group IV, respectively (Figure 5a ). SOD protects tissues against ROS by catalyzing their removal and catalase is a hem-protein involved in detoxifying significant amounts of H 2 O 2 [16] . Reduced activities of these enzymes in liver and pancreas during diabetes are associated with several harmful effects due to accumulation of superoxide and H 2 O 2 [17] . The SOD activity of the non-diabetic control (Group I) was about 23 U/mg protein, which was reduced by 35 and 40 % in the diabetic control (Group II) at 2 and 3 weeks of STZ treatment, respectively. Treatment with cerin and cerin ox increased SOD activity with greater increase in the presence of cerin (Figure 5b) . Similarly, a significant reduction in catalase activity was observed in diabetic control, which was alleviated to values closer to that of normal control (Group-I) on treatment with cerin and cerin ox (Figure 5c ). The decline in GSH content, SOD and CAT activities are consistent with other reports on diabetic subjects and in animals with experimental diabetes [3] . Decreased antioxidant enzyme activity in the diabetic control could be due to their non-enzymatic glycation at persistently elevated glucose level. Previous works have shown the inhibitory effect of glycation on SOD activity. However, some studies have also indicated increased SOD activity in STZ-induced diabetic rats [18, 19] .
In conclusion, friedelan triterpenoids oxygenated at 'ring A' showed anti-diabetic activity in STZ-induced diabetic rat models. These compounds maintained the homeostatic glucose level by influencing the cellular events associated with the etiology of diabetes. The reversal of hyperglycemia was achieved by maintaining (i) mitotic activity of pancreatic β-cells, (ii) activities of antioxidants and (iii) activities of liver function enzymes. Further studies are needed to establish the detailed mechanism of action of friedelan triterpenoids in reestablishment of normal glycemic response.
Experimental

Plant materials and chemicals:
Fresh cork was collected from the local market and cut into small pieces. All chemicals used were of analytical grade from either E. Merck, India or Sigma Chemical Company, USA. The biochemical kits were purchased from Span Diagnostic, India and Crest Biosystem, India.
Isolation of cerintriterpenoid from Q. suber and synthesis of its oxygenated derivative cerin ox :
The detailed method of isolation of cerin, the chemical synthesis of its hemi-synthetic derivatives and structural characterization of the compounds are described in our previous communication [11] . Cerin was obtained as slightly yellowish crystals (mp 260-261 o C). Oxidation of cerin in glacial acetic acid in the presence of anhydrous CrO 3 , followed by evaporation of the solvent at reduced pressure gave a yellow gummy residue. Purification of the residue over a column of silica gel gave a white powdered compound,4-oxa-3, 4-secofriedelan-3oicacid (cerin ox ) of mp 214-215 o C.
Animals:
Male Sprague rats (5 week age) were kept in propylene cages under standard laboratory conditions (24 ± 2 o C, 50 ± 10% RH and 12 h light/dark cycle). All rats were fed a semi purified basal diet (Table 1 ) and demineralized drinking water ad libitum. The rats were acclimatized for one week before the experimental treatments. All the animals were cared for in compliance with guidelines of the Institutional Animal Ethics Committee (IEAC) of University of North Bengal (NBU/IEAC/25/263/2011-AWD-2012).
Induction of diabetes mellitus: Streptozotocin (Sigma Chemicals
Co., St. Louis, MO, USA) was dissolved in cold 0.01 M citrate buffer, pH 4.5, and always prepared freshly before use. In rats of 6 weeks age, hyperglycemia was induced by a single intraperitoneal (ip) injection of STZ at a dose of 60 mg/kg after overnight fasting. Control rats were injected with cold citrate buffer (0.01M, pH 4.5) intraperitoneally. Rats attaining a stable plasma glucose level of >250 mg/dL following a STZ treatment span of 4 days were considered diabetic and selected for further studies.
Experimental design: All rats were randomly divided into four groups of 10 each: Group I: Normal control received vehicle daily for 3 weeks. Group II: Diabetic control received vehicle daily for 3 weeks. Group III: Diabetic rat + cerin (3 mg/kg, oral) daily for 3 weeks by gavage in vegetable oil. Group IV: Diabetic rat + cerin ox (3 mg/kg, oral) daily for 3 weeks by gavage in vegetable oil. After 3 weeks of treatment, blood samples were collected in plastic centrifuge tubes and allowed to clot at 4°C for 1h followed by centrifugation at 4000 rpm for 15 min to obtain the serum. Animals were then sacrificed and pancreas and liver were separated.
Histopathology of pancreas and liver:
The organs were removed and fixed in 10 % buffered formalin. After fixation, tissues were embedded in paraffin; solid sections were cut at 3-4 μm thickness and stained with eosin and hematoxylin. The sections were examined under a light microscope at a magnification of 40X and photographed.
Estimation of blood glucose: Blood glucose was assayed by the glucose oxidase/peroxidase method using a standard reagent kit (Span Diagnostic, India).
SGOT, SGPT, ALP, ACP activities:
SGOT and SGPT activities in blood serum were measured by the method of Reitman and Frankel [20] using a standard reagent kit (Crest Biosystem, India). SGOT (EC 2.6.1.1) and SGPT (EC 2.6.1.2) activities were expressed in units/mL. ALP (EC 3.1.3.1) and ACP (EC 3.1.3.2) activities in blood serum were measured by the method of King and King [21] with modifications, using a standard reagent kit (Crest Biosystem, India). ALP and ACP activity was measured in a KA unit.
Antioxidant assay: Five hundred mg of fresh liver tissue was homogenized in 5 mL of 0.1 M phosphate buffer saline (pH 7.4).
Homogenate was centrifuged at 1000 rpm for 10 min at 4 o C and supernatant was used for estimation of GSH content, and SOD and CAT activities.
GSH assay: GSH was estimated following the method described by Ellman [22] using DTBN reagent. The amount of GSH was expressed in μmol.
SOD assay:
The SOD (EC 1.15.1.1) activity was determined by the method of Marklund [23] through inhibition of the reduction of nitro blue tetrazolium (NBT) in the presence of reduced nicotinamide adenine dinucleotide (NADH) and phenazine. One unit of enzyme activity is definedas the enzymatic reaction giving 50% inhibition of NBT reduction in 1 min under the assay conditions and expressed as units/mg protein.
CAT assay: CAT (EC 1.11.1.6) activity was measured by the method of Aebi [24] . Activity of catalase was expressed as units/mg protein.
